Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-072826
Filing Date
2025-05-15
Accepted
2025-05-15 17:03:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13065
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 101632
  Complete submission text file 0000950170-25-072826.txt   155070
Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

EIN.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 105 MAXESS ROAD STE. 124 MELVILLE NY 11747
Business Address 105 MAXESS ROAD STE. 124 MELVILLE NY 11747 (631) 574 -4436
Sharps Technology Inc. (Subject) CIK: 0001737995 (see all company filings)

EIN.: 823751728 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93631 | Film No.: 25955165
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)